Dublin, Oct. 30, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/rqc6pg/global)
has announced the addition of the "Global
Neurostimulation Devices Market 2012-2016" report to their
offering.
Analysts forecast the Global Neurostimulation Devices market to
grow at a CAGR of 15.3 percent over the period 2012-2016. One of
the key factors contributing to this market growth is the
increasing prevalence of neurological disorders. The Global
Neurostimulation Devices market has also been witnessing an
increasing demand for minimally invasive procedures to treat
neurological disorders. However, the availability of alternative
drug therapy could pose a challenge to the growth of this
market.
The key vendors dominating this space are Medtronic Inc., St. Jude
Medical Inc., Boston Scientific Corp., and Cyberonics Inc.
The other vendors mentioned in the report are Afferent Corp.,
Cyberkinetics Neurotechnology Systems Inc., Synapse Biomedical
Inc., SPR Therapeutics LLC, NeuroVista Corp., and Neuros Medical
Inc.
TechNavio recognizes the following companies as the key players in
the Global Neurostimulation Devices Market: Medtronic Inc., St.
Jude Medical Inc., Boston Scientific Corp., and Cyberonics
Inc.
Commenting on the report, an analyst from the healthcare team
said:''An increasing demand for minimally invasive devices has been
noticed among members of the rapidly aging population across the
world, and this is expected to spark the growth of the Global
Neurostimulation Devices market. This is because minimally invasive
surgery causes less pain, reduces the duration of the recovery
process, causes minimal injuries, has a low risk of infection, and
minimizes bleeding. Moreover, less invasive methods are cost
efficient when compared to invasive methods, and this is expected
to increase the demand for them in the near future. This trend will
have a positive impact on the growth of the market.''
According to the report, one of the major factors driving the
market is the growth of the patient population in terms of
epilepsy, depression, stroke, anxiety disorders, and Parkinson's
disease, which increases the demand for neurostimulation
devices as neurostimulation is considered to be a more effective
and safer therapy.
For more information visit http://www.researchandmarkets.com/research/rqc6pg/global
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Medical Devices